marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 03-15-2024
Brickell Biotech Balance Sheet 2011-2024 | BBI
Annual Balance Sheet Brickell Biotech
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -29.7 M | -7.08 M | -7.23 M | -24.8 M | -5.07 M | -13.4 M | -20.5 M | -38.8 M | -43.2 M | -38.7 M |
Long Term Debt |
- | - | - | 146 K | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
- | 49 K | 69 K | 74 K | 78 K | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 146 K | 73 K | - | - | - | 359 K | 856 K | 1.29 M | 1.66 M | 1.96 M |
Total Current Liabilities |
1.66 M | 3.08 M | 4.81 M | 6.35 M | 10.5 M | 3.58 M | 16.9 M | 7.14 M | 4.16 M | 5.2 M | 3.65 M | 5.78 M | 6.46 M |
Total Liabilities |
- | - | - | 6.5 M | 10.6 M | 3.58 M | 16.9 M | 7.14 M | 4.52 M | 6.06 M | 4.94 M | 7.44 M | 8.42 M |
Deferred Revenue |
- | - | - | - | 1.8 M | 30 K | 11.7 M | 3.02 M | 250 K | - | 150 K | 150 K | 99 K |
Retained Earnings |
-172 M | -166 M | -145 M | -106 M | -85 M | -442 M | -427 M | -414 M | -405 M | -396 M | -379 M | -348 M | -325 M |
Total Assets |
11.6 M | 10.3 M | 29.7 M | 33.6 M | 18.1 M | 52.3 M | 80.5 M | 52.3 M | 49.9 M | 58 M | 66.4 M | 96.5 M | 68.8 M |
Cash and Cash Equivalents |
10.9 M | 8.68 M | 26.9 M | 30.1 M | 7.23 M | 11.9 M | 24.8 M | 5.07 M | 13.4 M | 20.5 M | 38.8 M | 43.2 M | 38.7 M |
Book Value |
11.6 M | 10.3 M | 29.7 M | 27.1 M | 7.57 M | 48.8 M | 63.6 M | 45.1 M | 45.4 M | 51.9 M | 61.4 M | 89.1 M | 60.3 M |
Total Shareholders Equity |
9.93 M | 7.19 M | 24.9 M | 27.1 M | 7.57 M | -71.6 M | 63.6 M | 45.1 M | 45.4 M | 51.9 M | 61.4 M | 89.1 M | 60.3 M |
All numbers in USD currency
Quarterly Balance Sheet Brickell Biotech
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | 18 K | 36 K | - | - | 7 K | - | 53 K | 73 K | 73 K | 73 K | 73 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
- | - | - | - | - | - | - | 4.81 M | 4.22 M | 6.72 M | 9.71 M | 6.5 M | 6.5 M | 6.5 M | 6.5 M | 10.6 M | 10.6 M | 10.6 M | 10.6 M | 22.1 M | 22.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | 142 K | 750 K | 1.8 M | 1.8 M | 1.8 M | 1.8 M | 8.12 M | 8.12 M | 30 K | 86 K | 11.7 M | 7.8 M | 7.2 M | 5.32 M | 3.02 M | 3.02 M | 3.02 M | 3.02 M | 250 K | 250 K | 250 K | 250 K | - | - | - | - | 150 K | 150 K | 150 K | 150 K | 150 K | 150 K | 150 K | 150 K | 99 K | 99 K | 99 K | 99 K |
Retained Earnings |
-171 M | -173 M | -171 M | -166 M | - | -156 M | -155 M | -145 M | -139 M | -126 M | -115 M | -106 M | -106 M | -106 M | -106 M | -85 M | -85 M | -85 M | -85 M | -71.6 M | -71.6 M | -442 M | -442 M | -427 M | -427 M | -427 M | -427 M | -414 M | -414 M | -414 M | -414 M | -405 M | -405 M | -405 M | -405 M | -396 M | -396 M | -396 M | -396 M | -379 M | -379 M | -379 M | -379 M | -348 M | -348 M | -348 M | -348 M | -325 M | -325 M | -325 M | -325 M |
Total Assets |
13.1 M | 9.84 M | 12 M | 10.3 M | - | 18.5 M | 20.8 M | 29.7 M | 24.2 M | 29.1 M | 38.9 M | 33.6 M | 33.6 M | 33.6 M | 33.6 M | 18.1 M | 18.1 M | 18.1 M | 18.1 M | 8.75 M | 8.75 M | 52.3 M | 52.3 M | 80.5 M | 80.5 M | 80.5 M | 80.5 M | 52.3 M | 52.3 M | 52.3 M | 52.3 M | 49.9 M | 49.9 M | 49.9 M | 49.9 M | 58 M | 58 M | 58 M | 58 M | 66.4 M | 66.4 M | 66.4 M | 66.4 M | 96.5 M | 96.5 M | 96.5 M | 96.5 M | 68.8 M | 68.8 M | 68.8 M | 68.8 M |
Cash and Cash Equivalents |
12 M | 8.95 M | 10.8 M | 8.68 M | 11.2 M | 14.5 M | 17.3 M | 26.9 M | 21.4 M | 24.4 M | 34.8 M | 30.1 M | 30.1 M | 30.1 M | 30.1 M | 7.23 M | 7.23 M | 7.23 M | 7.23 M | 8.07 M | 8.07 M | 11.9 M | 11.9 M | 24.8 M | 24.8 M | 24.8 M | 24.8 M | 5.07 M | 5.07 M | 5.07 M | 5.07 M | 13.4 M | 13.4 M | 13.4 M | 13.4 M | 20.5 M | 20.5 M | 20.5 M | 20.5 M | 38.8 M | 38.8 M | 38.8 M | 38.8 M | 43.2 M | 43.2 M | 43.2 M | 43.2 M | 38.7 M | 38.7 M | 38.7 M | 38.7 M |
Book Value |
- | - | - | 10.3 M | - | 18.5 M | 20.8 M | 24.9 M | 20 M | 22.4 M | 29.1 M | 27.1 M | 27.1 M | 27.1 M | 27.1 M | 7.57 M | 7.57 M | 7.57 M | 7.57 M | -13.3 M | -13.3 M | 52.3 M | 52.3 M | 80.5 M | 80.5 M | 80.5 M | 80.5 M | 52.3 M | 52.3 M | 52.3 M | 52.3 M | 49.9 M | 49.9 M | 49.9 M | 49.9 M | 58 M | 58 M | 58 M | 58 M | 66.4 M | 66.4 M | 66.4 M | 66.4 M | 96.5 M | 96.5 M | 96.5 M | 96.5 M | 68.8 M | 68.8 M | 68.8 M | 68.8 M |
Total Shareholders Equity |
10.9 M | 7.99 M | 9.87 M | 7.19 M | 11.2 M | 15.6 M | 16 M | 24.9 M | 20 M | 22.4 M | 29.1 M | 27.1 M | 27.1 M | 27.1 M | 27.1 M | 7.57 M | 7.57 M | 7.57 M | 7.57 M | -71.6 M | -71.6 M | 48.8 M | 48.8 M | -59.9 M | 63.6 M | 63.6 M | 63.6 M | 45.1 M | 45.1 M | 45.1 M | 45.1 M | 45.4 M | 45.4 M | 45.4 M | 45.4 M | 51.9 M | 51.9 M | 51.9 M | 51.9 M | 61.4 M | 61.4 M | 61.4 M | 61.4 M | 89.1 M | 89.1 M | 89.1 M | 89.1 M | 60.3 M | 60.3 M | 60.3 M | 60.3 M |
All numbers in USD currency